About Cormay Diagnostics
The lifeline to better health
Cormay Diagnostics makes affordable to small and mid-size clinical laboratories all over the world the cutting-edge technology and performance demanded by large clinical laboratories.
Combining the 35-years experienced manufacturer of reagents, Cormay with the outstanding technology knowledge of Swiss hematology company, Orphee, we work together every day to build the IVD brand that can be trusted.
Your trust is in the core of everything we do.
We act in over 120 countries and connect distributors all over the world with world class technology & performance for small & medium size clinical laboratories. With more than 20 000 sold analyzers we create a competetive edge in ivd market.
We are constantly developing innovative In-Vitro Diagnostic solutions to accurately uncover the truth hidden in a single drop of blood. Our actions help to understand the known and discover the unknown, leading to the earliest detection, treatment and monitoring of the health of patients all over the world.
Our cutting-edge In-Vitro Diagnostic solutions provide the lifeline that connects doctors and clinicians to their patients to deliver a positive health outcome.
We manufacture products that deliver tests results you can trust.
We supply high-quality in-vitro diagnostic solutions all over the world.
We comply with the legal requirements.
We care about productivity to provide our customers with competitive products.
We want to meet our customers' expectations.
- The Foreign Enterprise CORMAY is established, the first Polish private company producing reagents for medical laboratories
- First CE marking by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
- License Agreement for Reagents Production for Swiss company Hoffman–La Roche®
- Development and implementation of liquid Liquick Cor®
- Approval of the first patent PAT 157456 (new technology of bilirubin total reagents preparation
- First certification ISO 9001 standard
- Launching the production line of hematological reagents
- Cooperation with the Swiss company Orphée
- Expansion of the business to the veterinary market
- Launch of 1st Generation 5-DIFF Analyzer Mythic 22 OT
- August 20, 2009 - debut on the Warsaw Stock Exchange
- First certification ISO 13485 standard (Quality Management System for Medical Devices)
- Launch of 1st Generation Accent Analyzers 100–200 tests/hr
- Acquisition of the Swiss company, Orphée S.A.
- Expansion and modernization of own R & D department and registration own diagnostic laboratory – DIAGNOSTIC CUBE®
- Launch of 2nd Generation 5-DIFF Analyzer Mythic 22 AL
- Consolidating the ISO certification of Cormay and Orphee
- Launch of II Generation 5-DIFF Analyzer Mythic 60
- Launch of New Generation Multi-Patented Accent Analyzers 120-320 tests/hr
- Launch of the new group brand – CORMAY DIAGNOSTICS